The fusions BCR‐ABL1, TCF3‐PBX1, ETV6‐RUNX1, and KMT2A‐variant are recurrent genetic abnormalities with biological significance in B‐ALL [3]. This evidence concerns the gene PBX1 and acute lymphoblastic leukemia.